Jessner's lymphocytic infiltrate

2
Jessner's lymphocytic infiltrate

Lymphocytic infiltrate of Jessner (LID) is a rare inflammatory disorder of the dermis characterized by the formation of lymphocytic infiltrates, resulting in the development of localized erythematous papules or plaques on the skin. The areas most commonly affected are the face, neck, and upper body. Clinically, it appears as asymmetrically distributed, multiple, well-defined papules that may vary in size and texture. The disease is not a neoplastic process and in most cases resolves spontaneously without significant treatment. However, in some cases, intervention may be required to relieve symptoms and speed up recovery.

History of the disease and interesting historical facts

Jessner's lymphocytic infiltrate was first described in 1946 by the American dermatologist T. Jessner, who noted its clinical features and characteristic pathomorphological changes. Initially, the disease was described as self-sufficient, but with the development of dermatological science, studies were conducted that showed the possibility of its association with endocrine disorders, allergic reactions and some infectious diseases. Over the next decades, several cases were recorded where the disease was observed in patients with primary or secondary immune deficiency.

Epidemiology

The epidemiology of Jessner's lymphocytic infiltrate has not been studied in detail, but existing data suggest that the disease occurs predominantly in people aged 20 to 50 years. The incidence of LID is independent of gender, but there are more cases in women, which may be due to hormonal factors. The prevalence is estimated to be about 0.3–0.5% among all dermatological diseases, but accurate data are difficult to obtain due to the rarity of the disease and the lack of systematic information.

Genetic predisposition to this disease

A proven genetic predisposition to Jessner's lymphocytic infiltrate remains unclear. Scientific studies have not identified clear mutations or genetic markers directly associated with this disease. However, existing data suggest a possible connection with immune-mediated processes, suggesting a role for factors influencing the immune response. Some scientists suggest that certain polymorphisms in genes responsible for the regulation of inflammatory processes may increase the likelihood of developing LID.

Risk factors for the development of this disease

Risk factors for Jessner's lymphocytic infiltrate include both physical and chemical influences. The main factors include:

  • Mechanical irritation of the skin (frequent injuries and rubbing);
  • Changes in hormonal levels (pregnancy, menopause);
  • Atopic dermatitis and other allergic reactions;
  • Viral infections (eg, herpes viruses);
  • Environmental factors (street dirt and polluted atmosphere);
  • Psychosomatic factors (stress and emotional stress).

Diagnosis of this disease

The diagnosis of Jessner's lymphocytic infiltrate is based on clinical manifestations and exclusion of other diseases. The main symptoms include:

  • The appearance of papules or plaques on the skin;
  • Erythema and edema in the area of the infiltrate;
  • Absence of itching or pain in most cases;

Laboratory tests usually help to exclude infectious and allergic processes. Radiological examinations are not used, but skin biopsy can be performed to confirm the diagnosis and pathomorphological analysis. Differential diagnosis includes diseases such as psoriasis, dermatitis, cutaneous leukemia and infectious diseases (e.g. fungal infections).

Treatment

Treatment of Jessner's lymphocytic infiltrate is conservative in most cases, including:

  • General treatment - compliance with hygiene rules and skin care;
  • Pharmacological treatment - use of corticosteroid ointments to reduce inflammation;
  • Surgical treatment - in rare cases, surgical removal of large or treatment-resistant plaque is indicated;
  • Other therapies - phototherapy may be effective in resistant cases.

List of medications used to treat this disease

The main groups of drugs used to treat LID:

  • Corticosteroids (hydrocortisone ointment, betamethasone);
  • Antiallergic drugs (benadryl);
  • Immunosuppressants (azathioprine and methotrexate in difficult cases);
  • Photosensitizers for phototherapy (psoralen);

Disease monitoring

Monitoring of Jessner's lymphocytic infiltrate includes periodic visits to a dermatologist to monitor changes in the skin condition and assess the effect of treatment. The prognosis is usually favorable, since the disease tends to resolve on its own. However, complications such as secondary infections or hypopigmentation in the area of the infiltrate are possible.

Age-related features of the disease

Jessner's lymphocytic infiltrate can manifest itself in people of different age groups, but in children and the elderly the disease occurs less frequently and is sometimes characterized by a milder course. In adolescents and young people, more vivid clinical manifestations are observed, which may be associated with active hormonal changes and increased reactivity of the immune system.

Questions and Answers

  • What is Jessner's lymphocytic infiltrate? It is an inflammatory skin disease that appears as papules or plaques with lymphocytic infiltrate in the dermis.
  • What are the main symptoms of the disease? The main symptoms include the appearance of individual papules, erythema and absence of itching in most cases.
  • What risk factors can trigger the disease? Risk factors include mechanical skin irritation, allergies, viral infections and stress.
  • How is Jessner's lymphocytic infiltrate treated? Treatment includes corticosteroid ointments, good hygiene and, in rare cases, surgery.
  • What is the prognosis for this disease? The prognosis is favorable, the disease most often goes away on its own, but monitoring is required to prevent complications.

Advice from Dr. Oleg Korzhikov:

For patients with Jessner's lymphocytic infiltrate, it is important to follow skin hygiene rules, avoid mechanical damage and injuries, and control emotional stress and stressful situations. When the first symptoms appear or the condition worsens, you should always seek medical help. Regular examinations by a dermatologist will help monitor the development of the disease and eliminate potential complications. It should be remembered that there are no specific methods of prevention, so it is worth focusing on general health and immune system maintenance.

2 thoughts on “Лимфоцитарный инфильтрат Джесснера

  1. Maica says:

    Hola, de casualidad me metí en esta página buscando un poco de respuestas a mi supuesto diagnostico en la piel, en 2022 llego el pico más evidente de placas supuestamente compatibles con la enfermedad linfocitaria de Jessner… en mi piel va y viene también al mismo tiempo me descubrieron l diabetes tipo 1 .. a los años he visto q me salen ls reacciones en la piel cuando o bien he tenido subida de azúcar o bien porque he tenido un estrés grande… lo que no me encaja es, que en mi caso me pican muchísimo hasta el punto de que no puedo ni dormir. Y aquí leo que “ausencia de picor” y ya no me cuadra porque… es el segundo problema además de la evidencia visual de la placa… me hicieron biopsy pero también ponía “compatible con…” realmente no lo deja claro… ya día de hoy sigo igual.
    Gracias y un saludo.

    1. Dr. Korzhykov says:

      El infiltrado linfocitario de Jessner es una afección benigna caracterizada por pápulas o placas rojas en cara, cuelo y espalda, que generalmente no produce picor (asintomáticas). Aunque pueden ser asintomáticas, en ocasiones pueden presentar picor leve o incluso ardor, pero por lo general, son lesiones que no descaman y no pican.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.